Last $28.42 USD
Change Today +0.03 / 0.11%
Volume 275.1K
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

wright medical group inc (WMGI) Snapshot

Open
$28.28
Previous Close
$28.39
Day High
$28.60
Day Low
$28.02
52 Week High
02/24/14 - $33.80
52 Week Low
04/19/13 - $22.34
Market Cap
1.4B
Average Volume 10 Days
588.8K
EPS TTM
$-2.94
Shares Outstanding
49.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for WRIGHT MEDICAL GROUP INC (WMGI)

wright medical group inc (WMGI) Related Bloomberg News

View More Bloomberg News

wright medical group inc (WMGI) Related Businessweek News

No Related Businessweek News Found

wright medical group inc (WMGI) Details

Wright Medical Group, Inc., a specialty orthopaedic company, provides extremity and biologic solutions that enable clinicians to alleviate pain and restore their patients’ lifestyles. The company offers products that are used primarily in foot and ankle repair, upper extremity products, and biologics products. Its extremity hardware products comprise implants and other devices to replace or reconstruct injured or diseased joints and bones of the foot, ankle, hand, wrist, fingers, toes, elbow, and shoulder. The company also provides biologic products, which are used to replace damaged or disease bone, stimulate bone growth, and provide other biological solutions for surgeons and their patients, as well as offers a bone graft product incorporating antibiotic delivery. Its biological products focus on supporting biological musculoskeletal repair by utilizing synthetic and human tissue-based materials. The company sells its products through a network of employee sales representatives, independent sales representatives, and stocking distributors in approximately 60 countries primarily in the United States, Europe, Asia, Canada, Australia, and Latin America. The company was founded in 1950 and is headquartered in Memphis, Tennessee.

898 Employees
Last Reported Date: 02/27/14
Founded in 1950

wright medical group inc (WMGI) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $750.0K
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $340.0K
Chief Operating Officer and Executive Vice Pr...
Total Annual Compensation: $500.0K
President of International
Total Annual Compensation: $564.0K
President of Extremities - Biologics
Total Annual Compensation: $340.0K
Compensation as of Fiscal Year 2013.

wright medical group inc (WMGI) Key Developments

Wright Medical Group, Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2013; Provides Earnings Guidance for the Fiscal Year 2014

Wright Medical Group Inc. announced unaudited consolidated earnings results for the fourth quarter and year ended December 31, 2013. For the quarter, net sales were $67,824,000 against $58,380,000 a year ago. Operating loss was $23,240,000 against operating income of $11,784,000 a year ago. Loss from continuing operations before income taxes was $24,749,000 against profit from continuing operations before income taxes $4,346,000 a year ago. Net loss from continuing operations was $135,211,000 or $2.88 per diluted share against net income from continuing operations of $1,644,000 or $0.04 per diluted share a year ago. Net loss was $135,029,000 or $2.88 per diluted share against net profit of $5,352,000 or $0.14 per diluted share a year ago. Adjusted operating loss was $10,887,000 against $187,000 a year ago. Adjusted LBITDA was $3,166,000 against adjusted EBITDA $6,144,000 a year ago. Adjusted loss from continuing operations before income taxes was $13,015,000 against $2,067,000 a year ago. Adjusted net loss from continuing operations was $7,879,000 against $1,894,000 a year ago. Adjusted net loss was $5,438,000 or $0.17 per diluted share against $386,000 or $0.05 per diluted share a year ago. Negative free cash flow was $57,340,000 against positive free cash flow of $5,038,000 a year ago. LBITDA was $14,818,000 against EBITDA of $13,554,000 a year ago. For the year, net sales were $242,330,000 against $214,105,000 a year ago. Operating loss was $282,206,000 against operating income of $11,817,000 a year ago. Loss from continuing operations before income taxes was $230,403,000 against $3,387,000 a year ago. Net loss from continuing operations was $280,168,000 or $6.19 per diluted share against $3,387,000 or $0.09 per diluted share a year ago. Net loss was $273,945,000 or $6.05 per diluted share against net profit of $5,284,000 or $0.14 per diluted share a year ago. Adjusted operating loss was $34,661,000 against operating income of $2,178,000 a year ago. Adjusted LBITDA was $5,945,000 against adjusted EBITDA $27,303,000 a year ago. Adjusted loss from continuing operations before income taxes was $42,126,000 against $4,619,000 a year ago. Adjusted net loss from continuing operations was $25,220,000 or $0.56 per diluted share against $3,780,000 or $0.10 per diluted share a year ago. Adjusted net loss was $21,535,000 or $0.56 per diluted against $9,006,000 or $0.10 per diluted a year ago. Negative free cash flow was $74,131,000 against positive free cash flow of $49,499,000 a year ago. LBITDA was $192,503,000 against EBITDA of $25,960,000 a year ago. The company anticipates full-year 2014 net sales from continuing operations, or Extremity and Biologics revenue, to be in the range of $305 million to $312 million. This represents a growth rate of 26% to 29% and an organic growth rate of 13% to 15% over last year. This range anticipates some potential minor, short-term dis-synergies due to the closing of the transactions with MicroPort, Biotech International, Solana Surgical and OrthoPro, and includes a negative impact from currency of approximately 1% as compared to 2013. The company projects 2014 adjusted LBITDA from continuing operations in the range of $20.0 million to $15.0 million. The company expects to exit 2014 with positive adjusted EBITDA. CapEx for 2014 is anticipated to be in the range of $50 million, $25 million of which is related to normal operations and $25 million of which is related to transition and integration activities.

Wright Medical Group Inc. Amends By-Laws

On February 13, 2014, the Board of Directors of Wright Medical Group Inc. amended the company's by-laws primarily to enhance the advance notice provisions to include stockholder proposals, additional informational requirements and the required timing of stockholder notices; specifically provide for remote communications equipment as a means of meeting attendance by stockholders; clarify that the Board may fix the number of directors, subject to the requirements of the company's Certificate of Incorporation and Delaware corporate law; specifically reference the Board's three presently standing committees and such other committees as the Board may establish; and revise the provision pertaining to amending or repealing the By-Laws to more closely conform to the company's Certificate of Incorporation.

Wright Medical Group Inc. Presents at Barclays Capital 2014 Global Healthcare Conference, Mar-11-2014 09:30 AM

Wright Medical Group Inc. Presents at Barclays Capital 2014 Global Healthcare Conference, Mar-11-2014 09:30 AM. Venue: Loews Miami Beach Hotel, Miami, Florida, United States. Speakers: Robert J. Palmisano, Chief Executive Officer, President and Director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WMGI:US $28.42 USD +0.03

WMGI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ArthroCare Corp $48.61 USD +0.11
Cyberonics Inc $62.02 USD +0.77
Exactech Inc $22.49 USD -0.16
ICU Medical Inc $55.98 USD -0.40
Tornier NV $18.38 USD +0.14
View Industry Companies
 

Industry Analysis

WMGI

Industry Average

Valuation WMGI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.6x
Price/Book 2.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.0x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WRIGHT MEDICAL GROUP INC, please visit www.wmt.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.